$MRBK Cashflow Statement | Understand Stock

$MRBK

$18.72 +$0.06 (0.32%) Close

$MRBK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
(Gain) loss on sale of investment securities available-for-sale
Net amortization of investment premiums and discounts and change in fair value of equity securities
Depreciation and amortization (accretion), net
Provision for loan losses
Provision for credit losses
Amortization of issuance costs on subordinated debt
Stock based compensation
Net change in fair value of derivative instruments
Net change in fair value of loans held for sale
Net change in fair value of loans held for investment
Amortization and net impairment of servicing rights
Net gain on sale of MSRs
Gain on sale of OREO
SBA loan income
Proceeds from sale of loans
Loans originated for sale
Mortgage banking income
Increase in accrued interest receivable
Lease early termination
Increase in other assets
Earnings from investment in bank owned life insurance
Increase in deferred income tax
Decrease in accrued interest payable
Increase (decrease) in other liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Activity in available-for-sale securities:
Maturities, repayments and calls
Sales
Purchases
Activity in held-to-maturity securities:
Maturities, repayments and calls
Purchases
Proceeds from sale of OREO
Proceeds from sale of MSRs
Proceeds from sale of loans held for investment
Net purchases of restricted investments in bank stocks
Net increase in loans
Purchases of premises and equipment
Net purchase of bank owned life insurance
Disposal of premise and equipment
Net cash used in investing activities
Cash flows from financing activities:
Net increase in deposits
Decrease in short-term borrowings
Decrease in short-term borrowings with original maturity > 90 days
Increase (decrease) in short-term borrowings
Increase in long-term debt
(Decrease) increase in long-term debt
Decrease in long-term debt
Repayment of subordinated debt
Proceeds from issuance of subordinated debt
Issuance costs on subordinated debt
Net purchase of treasury stock
Dividends paid
Stock based awards and exercises
Shares purchased for ESOP plan
Proceeds from issuance of common stock
Net cash provided by financing activities

Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest
Federal
State
Total Income taxes
Transfers from loans held for sale to loans held for investment
Transfers from loans held for investment to loans held for sale
Carrying value of residential portfolio loans sold
Net loans sold, not settled
Non-cash transfers from loans receivable to OREO
Transfer of securities from AFS to HTM
Lease liabilities arising from obtaining right-of-use assets
Non-cash transfers from loans receivable to repossessed assets

Comments